Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A two-arm, randomised, double-blind, placebo-controlled, multicenter phase II study to evaluate safety and tolerability and to explore the neuroprotective effect of atacicept as assessed by Optical Coherence Tomography (OCT) in subjects with Optic Neuritis (ON) as Clinically Isolated Syndrome (CIS) over a 36 week treatment course https://kusajili.fr:443/Trial/HgxvlE7u8E6UZpaYuSLy2Q%24a-two-arm-randomised-double-blind-placebo-controlled-multicenter-phase-ii-study-to-evaluate-safety-and-tolerability-and-to-expl
I have read and accept the terms of use of the site and the Privacy Policy
Send your message